Recent Advancements in Oral Anticoagulants: A Systematic Review

Authors

  • Ram Kripal Sharma University Of South China, Hengyang, Hunan, China

DOI:

https://doi.org/10.3126/nmj.v5i1.44920

Keywords:

Atrial fibrillation, COVID-19, Direct/New oral anticoagulants, Deep Vein Thrombosis, Pulmonary embolism, Venous thromboembolism, Vitamin K Antagonist

Abstract

Anticoagulants are medications that are administered to patients with clotting issues. Major issues include atrial fibrillation, venous thromboembolism/deep vein thrombosis, and pulmonary embolism. However, recent studies show the increased use of these medications in the treatment and management of COVID-19.  

This paper has been designed as a systematic Literature review based on PRISMA strategy. Data were collected by conducting exhaustive research on major electronic databases i.e., SCOPUS, Web of Science, EMBASE, ProQuest, ScienceDirect, and Google Scholar. A total of 52 studies were included in this review. These studies were selected from the period 2011-2021. The overall study revealed the advancements of DOACs or NOACs in comparison to Warfarin, revealed the findings of various food, drug, and another kind of products that interfere with oral anticoagulants, and advancements in terms of treatment of DVT/VTE, pulmonary embolism, and arterial fibrillation by use of oral anticoagulants and the role of anticoagulation in COVID-19.

Downloads

Download data is not yet available.
Abstract
178
PDF
222
Cover NMJ

Downloads

Published

2022-06-30

How to Cite

Sharma, R. K. (2022). Recent Advancements in Oral Anticoagulants: A Systematic Review. Nepalese Medical Journal, 5(1), 552–558. https://doi.org/10.3126/nmj.v5i1.44920

Issue

Vol. 5 No. 1 (2022)

Section

Review Articles

License

Copyright (c) 2022 Ram Kripal Sharma

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.

Copyright on any article published by Nepalese Medical Journal is retained by the author(s).

Authors grant Nepalese Medical Journal a license to publish the article and identify itself as the original publisher.

Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.